2 Musick
Irvine, CA 92618
United States
949-595-7200
http://endologix.com
Sector: Healthcare
Industry: Medical Instruments & Supplies
Full-time employees: 528
Name | Title | Pay | Exercised | Year born |
---|---|---|---|---|
Mr. John Onopchenko | CEO & Director | 1.3M | N/A | 1959 |
Mr. Vaseem Mahboob | Chief Financial Officer | 1.06M | N/A | 1969 |
Mr. Jeremy B. Hayden | Gen. Counsel | 944.67k | N/A | 1970 |
Dr. Matthew Thompson | Chief Medical Officer | 1.06M | N/A | 1962 |
Mr. Jeffrey S. Brown | Chief Operations Officer | N/A | N/A | N/A |
Endologix, Inc. develops, manufactures, markets, and sells medical devices for the treatment of abdominal aortic aneurysms in the United States and internationally. The company offers minimally-invasive endovascular aneurysm repair (EVAR), including AFX (Anatomical Fixation) endovascular AAA system, which is a minimally invasive delivery system; VELA Proximal Endograft, which is designed for the treatment of proximal aortic neck anatomies with AFX; and the Ovation abdominal stent graft system. It also provides endovascular aneurysm sealing system (EVAS) product that is based on the Nellix EVAS system to seal the aneurysm, and provides blood flow to the legs through two blood lumens. In addition, the company offers proximal aortic extensions and limb extensions, which allow physicians to customize the implant to fit the patient's anatomy; and accessories to facilitate the delivery of its EVAR and EVAS products, including compatible guidewires, inflation devices, and snares. It sells its products through direct sales force, and a network of third party distributors and agents. The company was formerly known as Radiance Medical Systems, Inc. and changed its name to Endologix, Inc. in May 2002. Endologix, Inc. was founded in 1992 and is headquartered in Irvine, California.
Endologix, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.